Trial Profile
A Phase II, Placebo and Baseline-Controlled Multi-Centre Study to Evaluate Eltoprazine in Aggressive Elderly Patients with Alzheimer's Dementia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Apr 2017
Price :
$35
*
At a glance
- Drugs Eltoprazine (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Therapeutic Use
- Acronyms Duphar
- 17 Apr 2017 Results published in an Amarantus Bioscience Holdings media release.
- 11 Dec 2015 New trial record
- 08 Dec 2015 Results published in an Amarantus Bioscience Holdings media release.